Back to search

United States· US:70518-3915_53ea8392-8014-a71d-e063-6294a90a1cf5

Diphenoxylate Hydrochloride and Atropine Sulfate

A medicinal product containing diphenoxylate hydrochloride; atropine sulfate, registered in United States by REMEDYREPACK INC..

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedDiphenoxylate Hydrochloride and Atrop…ATC—REGISTER NO.US:70518-3915_53ea839…PACKS LISTED1CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
DIPHENOXYLATE HYDROCHLORIDE; ATROPINE SULFATE
Manufacturer
REMEDYREPACK INC.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 1

  • ndc11
    70518-3915-1

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Diphenoxylate hydrochloride; atropine sulfate in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All diphenoxylate hydrochloride; atropine sulfate products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • Cyprus · Lomotil
  • Czechia · Reasec
  • Hungary · Reasec
  • Poland · Reasec
  • Slovakia · Reasec

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c71fc21a-e587-4b3c-b331-4d8903398ad3
GET /v1/drugs/c71fc21a-e587-4b3c-b331-4d8903398ad3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "2.5; .025",
  "substance": "DIPHENOXYLATE HYDROCHLORIDE; ATROPINE SULFATE",
  "productndc": "70518-3915",
  "dosage_form": "TABLET",
  "dea_schedule": "CV",
  "strength_unit": "mg/1; mg/1",
  "application_number": "ANDA213413",
  "marketing_category": "ANDA"
}

See everything about diphenoxylate hydrochloride; atropine sulfate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.